HYPD NASDAQ
Hyperion DeFi, Inc.
1W: +0.3%
1M: -19.6%
3M: -2.3%
YTD: -3.9%
$3.58
+0.14 (+4.22%)
Weekly Expected Move ±15.2%
$2
$3
$3
$4
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider+$0.6M
Congress—
ETF Holdings—
Key Statistics
Market Cap$17.1M
52W Range1.36-17.18
Volume561,574
Avg Volume411,095
Beta2.57
Dividend—
Analyst Ratings
Company Info
CEOHyunsu Jung
Employees13
SectorHealthcare
IndustryMedical - Devices
IPO Date2025-07-02
Websitehyperiondefi.com/
295 Madison Avenue
New York, NY 10017
US
New York, NY 10017
US
917 289 1117
About Hyperion DeFi, Inc.
A U.S.-based firm pivoting from ophthalmic drug-delivery tech (Optejet) to becoming the first Nasdaq-listed U.S. company with a cryptocurrency treasury denominated in HYPE tokens from the Hyperliquid blockchain; also operates a validator (âKinetiq à Hyperionâ) and continues DeFi staking strategies alongside ongoing development of Optejet UFD⢠for eye care.
Latest News
Hyperion DeFi (HYPD) Q1 2026 Earnings Transcript
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Hyperion DeFi Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Hyperion DeFi Schedules First Quarter Earnings Call for Thursday, May 14 at 8:00 a.m. ET
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Knox David R. | F-InKind | 20,831 | — | 2026-03-30 |
| Rubenstein Robert | A-Award | 75,000 | — | 2026-01-12 |
| Rubenstein Robert | 0 | — | 2026-01-12 | |
| Knox David R. | P-Purchase | 27,950 | $3.59 | 2025-12-31 |
| Strahlman Ellen R | P-Purchase | 12,112 | $3.60 | 2025-12-29 |